Evaluation of Stability of Thiopurine Metabolites Using a Validated LC-MS/MS Method.
10.3343/alm.2018.38.3.255
- Author:
In Young YOO
1
;
Kyunghoon LEE
;
Ok Ja JI
;
Hye In WOO
;
Soo Youn LEE
Author Information
1. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. suddenbz@skku.edu
- Publication Type:Brief Communication
- Keywords:
Thiopurine metabolites;
6-Thioguanine nucleotide;
6-Methylmercaptopurine nucleotide;
Mass spectrometry;
Stability
- MeSH:
Compliance;
Humans;
Mass Spectrometry;
Methods*;
Nucleotides;
Thioguanine
- From:Annals of Laboratory Medicine
2018;38(3):255-260
- CountryRepublic of Korea
- Language:English
-
Abstract:
Measurement of thiopurine metabolites is helpful to monitor adverse effects and assess compliance in patients on thiopurine treatment. The purpose of this study was to develop and validate an analytical method for measurement of thiopurine metabolites, thioguanine nucleotides (6-TGN) and 6-methylmercaptopurine nucleotide (6-MMPN), in RBCs. We developed and validated a liquid chromatography–tandem mass spectrometry (LC-MS/MS) method for the quantification of 6-TGN and 6-MMPN and evaluated the stability of the thiopurine metabolites in RBC and whole blood states without any preprocessing at various storage conditions. The linear range was 0.1–10 µmol/L and 0.5–100 µmol/L for 6-TGN and 6-MMPN, respectively. The mean extraction recovery at the two concentrations was 71.0% and 75.0% for 6-TGN, and 102.2% and 96.4% for 6-MMPN. Thiopurine metabolites in preprocessed RBC samples were stable at 25℃ and 4℃ after storage for 4 hours and at −70℃ for up to 6 months. However, 6-TGN decreased by 30% compared with the initial concentration when stored at −20℃ for 180 days. In whole blood states, 6-TGN decreased by about 20% at four days after storage at 4℃. We validated a reliable LC-MS/MS method and recommend that the patient's whole blood sample be preprocessed as soon as possible.
